Ignite Creation Date:
2024-05-06 @ 7:30 PM
Last Modification Date:
2024-10-26 @ 3:08 PM
Study NCT ID:
NCT06031610
Status:
RECRUITING
Last Update Posted:
2023-09-11
First Post:
2023-08-21
Brief Title:
Revascularization Effect on CSVD Burden in Carotid Artery Stenosis
Sponsor:
Zhejiang Provincial Peoples Hospital
Organization:
Zhejiang Provincial Peoples Hospital
Study Overview
Official Title:
Revascularization Effect on CSVD Burden in Carotid Artery Stenosis
Status:
RECRUITING
Status Verified Date:
2024-10
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
RECAS
Brief Summary:
RECAS is a prospective cohort of 1000 patients with carotid artery stenosis CAS and undergoing revascularization therapy or standard medication treatment alone The goal of this study is to validate whether CAS revascularization when compared to standard medication treatment alone can effectively reduce the progression of Cerebral small vessel disease CSVD burden as well as improve the severity of retinal pathologies and cognitive impairment Therefore Patients aged 40 years have more than 50 stenosis in unilateral carotid artery and sign informed consent will be recruited In this study patients will be asked to undergo Computed Tomography Angiography CTA Digital Subtraction Angiography DSA Computed Tomography Perfusion CTPmultimodal Magnetic Resonance Imaging MRI Optical Coherence Tomography Angiography OCTA and neuropsychological testing Estimated follow-up can be up to 10 years
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None